0001213900-19-021556.txt : 20191030 0001213900-19-021556.hdr.sgml : 20191030 20191030200231 ACCESSION NUMBER: 0001213900-19-021556 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191025 FILED AS OF DATE: 20191030 DATE AS OF CHANGE: 20191030 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mattes Glenn R. CENTRAL INDEX KEY: 0001568678 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39102 FILM NUMBER: 191181616 MAIL ADDRESS: STREET 1: 200 ROUTE 31 NORTH STREET 2: SUITE 104 CITY: FLEMINGTON STATE: NJ ZIP: 08822 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TFF Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001733413 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 824344737 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2600 VIA FORTUNA, SUITE 360 CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: 737-802-1973 MAIL ADDRESS: STREET 1: 2600 VIA FORTUNA, SUITE 360 CITY: AUSTIN STATE: TX ZIP: 78746 4/A 1 ownership.xml X0306 4/A 2019-10-25 2019-10-29 0 0001733413 TFF Pharmaceuticals, Inc. TFFP 0001568678 Mattes Glenn R. 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 1 1 0 0 President and CEO Common Stock 2019-10-25 4 P 0 10000 5.00 A 10000 D Common Stock 2019-10-25 4 P 0 10000 5.00 A 10000 I By Spouse Stock Options (Right to Buy) 5.00 2019-10-29 4 A 0 332868 0.00 A 2029-10-29 Common Stock 332868 945891 D The shares of common stock purchased in the Issuer's initial public offering. 25% of the options vest on the first anniversary of the grant and the remainder vest in equal quarterly installments over the next three years. /s/Glenn R. Mattes, by Kirk Allen Coleman, as Attorney-in-Fact 2019-10-30